TA
EVH icon

Tamarack Advisers’s Evolent Health EVH Stock Holding History

Tamarack Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125,000
Closed -$2.52M – 56
2021
Q1 		$2.52M Buy
+125,000
New +$2.38M 0.52% 36
2017
Q4 		– Sell
-75,000
Closed -$1.33M – 35
2017
Q3 		$1.33M Buy
+75,000
New +$1.55M 0.82% 22

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Tamarack Advisers's EVH Position: Q2 2021 in Review

Tamarack Advisers sold out of Evolent Health (EVH) in Q2 2021, closing a stake of 125,000 shares — an estimated $2.52M sold.

Tamarack Advisers first reported a position in EVH in Q3 2017 and held it in 2 quarters. The position peaked at $2.52M in Q1 2021. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2021.

  • Tamarack Advisers reported no remaining Evolent Health position as of Q2 2021 after selling out during the quarter.
  • Tamarack Advisers sold 125,000 Evolent Health shares in Q2 2021, an estimated $2.52M.
  • Tamarack Advisers first reported a position in Evolent Health in Q3 2017 and held it in 2 quarters.
  • Tamarack Advisers's Evolent Health position peaked at $2.52M in Q1 2021.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2021.

Based on Tamarack Advisers's 13F filing for Q2 2021, filed 13 Aug 2021.